Results 121 to 130 of about 1,168 (170)

Rapid reduction with cystic transformation of invasive giant prolactinoma following short term low dose cabergoline

Indian Journal of Endocrinology and Metabolism, 2012
Deep Dutta, Sujoy Ghosh, Satinath Mukhopadhyay, Subhankar Chowdhury   +3 more
doaj   +1 more source

The longest stalk: preserved pituitary function after regression of a giant prolactinoma. [PDF]

Pituitary, 2017
Lundgren JA, Oldfield EH, Marshall JC.
europepmc   +1 more source

A giant prolactinoma with nasopharyngeal extension presenting with nasal blockage and epistaxis. [PDF]

BMJ Case Rep, 2015
Sahoo JP, Kamalanathan S, Parida PK, Pillai V.   +3 more
europepmc   +1 more source

Giant prolactinoma mimicking low-tension glaucoma at presentation. [PDF]

BMJ Case Rep, 2015
Karl D, Gillan SN, Goudie C, Sanders R.
europepmc   +1 more source

Prolactinoma in males: a single center experience in Northern Africa. [PDF]

Med Pharm Rep
El Yamani N, Jamal A, Bouichrat N, Rouf S, Latrech H.   +4 more
europepmc   +1 more source

Chinese consensus on the diagnosis and treatment of prolactinomas (2025 edition). [PDF]

Chin Neurosurg J
Lin S, Chen Z, Ji L, Wang L, Zhang W, Tang X, Wu Y, Fan Q, Li J, Pan L, Yao Z, Deng C, Ye H, Li S, Zhu H, Zhao Y, Wang Y, Wu ZB, China Pituitary Adenoma Specialist Council.   +18 more
europepmc   +1 more source

Long-term cabergoline use does not predict degree of prolactinoma fibrosis nor significantly impact surgical outcomes. [PDF]

Pituitary
Mamelak AN, Fox R, Rosenberg Y, Gomez D, Cui Y, Ben-Shlomo A, Labadzhyan A, Liu NA, Bonert V, Cooper O.   +9 more
europepmc   +1 more source

Prognostic value of PANOMEN-3 classification for hypopituitarism in surgically and nonoperatively managed pituitary adenomas. [PDF]

Endocr Connect
Nakhleh A, Ayada G, Assalia Naffa M, Sviri G, Zolotov S.   +4 more
europepmc   +1 more source